Colgate-Palmolive's SWOT analysis: stock faces headwinds amid strong brand portfolio
Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.
Colgate-Palmolive price target lowered to $100 from $105 at Evercore ISI
Evercore ISI lowered the firm’s price target on Colgate-Palmolive (CL) to $100 from $105 and keeps an Outperform rating on the shares. Shares ...
Colgate-Palmolive price target lowered to $93 from $95 at Stifel
Stifel lowered the firm’s price target on Colgate-Palmolive (CL) to $93 from $95 and keeps a Hold rating on the shares. Following “mixed” 2024 ...
Why Colgate-Palmolive Stock Fell Today
Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line ...
Colgate-Palmolive anticipates strong 2025 growth with focus on premiumization and innovation
Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...
Naija Gist - Latest5d
13 Valentine’s Day Gift Ideas for Women Under ₦30,000
At the end of the day, the perfect Valentine’s gift isn’t about how much you spend but about the effort and thoughtfulness behind it. Whether it’s a beautifully wrapped perfume, a surprise date night, ...
Colgate-Palmolive is due for a turnaround, one analyst says. Here’s what can drive it.
Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.